Federal Register / Vol. 86, No. 156 / Tuesday, August 17, 2021 / Notices 45985 

DATES: Comments must be received on 

or before October 18, 2021, to be assured 

of consideration. 

ADDRESSES: Comments may be 

submitted electronically on 

WWW.REGULATIONS.GOV (EIB 92–36) 

or by email tara.pender@exim.gov, or by 

mail to Tara Pender, Export-Import 

Bank of the United States, 811 Vermont 

Ave. NW, Washington, DC 20571. The 

application tool can be reviewed at: 

https://www.exim.gov/sites/default/ 

files/pub/pending/eib92-36.pdf. 

FOR FURTHER INFORMATION CONTACT: To 

request additional information, please 

Tara Pender. 202–565–3655. 

SUPPLEMENTARY INFORMATION: This 

collection of information is necessary, 

pursuant to 12 U.S.C. Sec. 635(a)(1), to 

determine eligibility of the applicant for 

EXIM assistance. 

Title and Form Number: EIB 92–36 

Application for Issuing Bank Credit 

Limit (IBCL) Under Lender or ExporterHeld Policies. 

OMB Number: 3048–0016. 

Type of Review: Renewal. 

Need and Use: This form is used by 

an insured exporter or lender (or broker 

acting on its behalf) in order to obtain 

approval for coverage of the repayment 

risk of an overseas bank. The 

information received allows EXIM staff 

to make a determination of the 

creditworthiness of the foreign bank and 

the underlying export sale for EXIM 

assistance under its programs. 

Affected Public: This form affects 

entities involved in the export of U.S. 

goods and services. 

Annual Number of Respondents: 600. 

Estimated Time per Respondent: 1.2 

hours. 

Annual Burden Hours: 720 hours. 

Frequency of Reporting of Use: As 

needed. 

Government Expenses: 

Reviewing time per year: 600 hours. 

Average Wages per Hour: $42.50. 

Average Cost per Year: $25,500 (time 

* wages). 

Benefits and Overhead: 20%. 

Total Government Cost: $30,600. 

Bassam Doughman, 

IT Specialist. 

[FR Doc. 2021–17645 Filed 8–16–21; 8:45 am] 

BILLING CODE 6690–01–P 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

standards enumerated in the BHC Act 

(12 U.S.C. 1842(c)). 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington, DC 20551–0001, not later 

than September 16, 2021. 

A. Federal Reserve Bank of Chicago 

(Colette A. Fried, Assistant Vice 

President) 230 South LaSalle Street, 

Chicago, Illinois 60690–1414: 

1. Ottawa Bancorp, Inc., Ottawa, 

Illinois; to become a bank holding 

company upon the conversion of its 

wholly-owned subsidiary, Ottawa 

Savings Bank, Ottawa, Illinois, from a 

federally-chartered savings association 

to a state-chartered bank. 

Board of Governors of the Federal Reserve 

System, August 12, 2021. 

Ann Misback, 

Secretary of the Board. 

[FR Doc. 2021–17630 Filed 8–16–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Meeting of the Community Preventive 

Services Task Force (CPSTF) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: The Centers for Disease 

Control and Prevention within the 

Department of Health and Human 

Services announces the next meeting of 

the Community Preventive Services 

Task Force (CPSTF) on October 20–21, 

2021. 

DATES: The meeting will be held on 

Wednesday, October 20, 2021, from 

10:00 a.m. to 5:00 p.m. EDT, and 

Thursday, October 21, 2021, from 10:00 

a.m. to 5:00 p.m. EDT. 

ADDRESSES: The meeting will be held 

via web conference. 

FOR FURTHER INFORMATION CONTACT: 

Arielle Gatlin, Office of the Associate 

Director for Policy and Strategy; Centers 

for Disease Control and Prevention, 

1600 Clifton Road NE, MS–V–25–5, 

Atlanta, GA 30329, phone: (404) 498– 

4512, email: CPSTF@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Meeting Accessibility: The CPSTF 

meeting will be held virtually via web 

conference. CDC will send web 

conference information to registrants 

upon receipt of their registration. All 

meeting attendees must register by 

October 13, 2021 to receive the web 

conference information for the October 

meeting. CDC will email web conference 

information from the CPSTF@cdc.gov 

mailbox. 

To register for the meeting, 

individuals should send an email to 

CPSTF@cdc.gov and include the 

following information: name, title, 

organization name, organization 

address, phone, and email. 

Public Comment: Individuals who 

would like to make public comments 

during the October meeting must state 

their desire to do so with their 

registration and provide their name and 

organizational affiliation and the topic 

to be addressed (if known). The 

requestor will receive instructions for 

the public comment process for this 

virtual meeting after the request is 

received. A public comment period 

follows the CPSTF’s discussion of each 

systematic review and will be limited, 

up to three minutes per person. Public 

comments will become part of the 

meeting summary. 

Background on the CPSTF: The 

CPSTF is an independent, nonfederal 

panel whose members are appointed by 

the CDC Director. CPSTF members 

represent a broad range of research, 

practice, and policy expertise in 

prevention, wellness, health promotion, 

and public health. The CPSTF was 

convened in 1996 by the Department of 

Health and Human Services (HHS) to 

identify community preventive 

programs, services, and policies that 

increase health, longevity, save lives 


khammond on DSKJM1Z7X2PROD with NOTICES
45986 Federal Register / Vol. 86, No. 156 / Tuesday, August 17, 2021 / Notices 

and dollars, and improve Americans’ 

quality of life. CDC is mandated to 

provide ongoing administrative, 

research, and technical support for the 

operations of the CPSTF. During its 

meetings, the CPSTF considers the 

findings of systematic reviews of 

existing research and practice-based 

evidence and issues recommendations. 

CPSTF recommendations are not 

mandates for compliance or spending. 

Instead, they provide information about 

evidence-based options that decision 

makers and stakeholders can consider 

when they are determining what best 

meets the specific needs, preferences, 

available resources, and constraints of 

their jurisdictions and constituents. The 

CPSTF’s recommendations, along with 

the systematic reviews of the evidence 

on which they are based, are compiled 

in the The Community Guide. 

Matters proposed for discussion: The 

agenda will consist of deliberation on 

systematic reviews of literature and is 

open to the public. Topics will include 

Cancer Screening; HIV Prevention; 

Nutrition, Physical Activity, and 

Obesity; Social Determinants of Health, 

and Violence Prevention. Information 

regarding the start and end times for 

each day, and any updates to agenda 

topics, will be available on the 

Community Guide website 

(www.thecommunityguide.org) closer to 

the date of the meeting. 

The meeting agenda is subject to 

change without notice. 

Dated: August 11, 2021. 

Sandra Cashman, 

Executive Secretary, Centers for Disease 

Control and Prevention. 

[FR Doc. 2021–17556 Filed 8–16–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–9131–N] 

Medicare and Medicaid Programs; 

Quarterly Listing of Program 

Issuances—April Through June 2021 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice. 

SUMMARY: This quarterly notice lists 

CMS manual instructions, substantive 

and interpretive regulations, and other 

Federal Register notices that were 

published from April through June 

2021, relating to the Medicare and 

Medicaid programs and other programs 

administered by CMS. 

FOR FURTHER INFORMATION CONTACT: It is 

possible that an interested party may 

need specific information and not be 

able to determine from the listed 

information whether the issuance or 

regulation would fulfill that need. 

Consequently, we are providing contact 

persons to answer general questions 

concerning each of the addenda 

published in this notice. 

Addenda Contact Phone No. 

I CMS Manual Instructions ......................................................................................................... Ismael Torres ..................... (410) 786–1864 

II Regulation Documents Published in the Federal Register ................................................... Terri Plumb ......................... (410) 786–4481 

III CMS Rulings .......................................................................................................................... Tiffany Lafferty ................... (410) 786–7548 

IV Medicare National Coverage Determinations ........................................................................ Wanda Belle, MPA ............. (410) 786–7491 

V FDA-Approved Category B IDEs ............................................................................................ John Manlove ..................... (410) 786–6877 

VI Collections of Information ...................................................................................................... William Parham .................. (410) 786–4669 

VII Medicare-Approved Carotid Stent Facilities ......................................................................... Sarah Fulton, MHS ............ (410) 786–2749 

VIII American College of Cardiology-National Cardiovascular Data Registry Sites .................. Sarah Fulton, MHS ............ (410) 786–2749 

IX Medicare’s Active Coverage-Related Guidance Documents ................................................ JoAnna Baldwin, MS .......... (410) 786–7205 

X One-time Notices Regarding National Coverage Provisions ................................................. JoAnna Baldwin, MS .......... (410) 786–7205 

XI National Oncologic Positron Emission Tomography Registry Sites ..................................... David Dolan, MBA .............. (410) 786–3365 

XII Medicare-Approved Ventricular Assist Device (Destination Therapy) Facilities .................. David Dolan, MBA .............. (410) 786–3365 

XIII Medicare-Approved Lung Volume Reduction Surgery Facilities ......................................... Sarah Fulton, MHS ............ (410) 786–2749 

XIV Medicare-Approved Bariatric Surgery Facilities .................................................................. Sarah Fulton, MHS ............ (410) 786–2749 

XV Fluorodeoxyglucose Positron Emission Tomography for Dementia Trials .......................... David Dolan, MBA .............. (410) 786–3365 

All Other Information ..................................................................................................................... Annette Brewer .................. (410) 786–6580 

SUPPLEMENTARY INFORMATION: 

I. Background 

The Centers for Medicare & Medicaid 

Services (CMS) is responsible for 

administering the Medicare and 

Medicaid programs and coordination 

and oversight of private health 

insurance. Administration and oversight 

of these programs involves the 

following: (1) Furnishing information to 

Medicare and Medicaid beneficiaries, 

health care providers, and the public; 

and (2) maintaining effective 

communications with CMS regional 

offices, state governments, state 

Medicaid agencies, state survey 

agencies, various providers of health 

care, all Medicare contractors that 

process claims and pay bills, National 

Association of Insurance Commissioners 

(NAIC), health insurers, and other 

stakeholders. To implement the various 

statutes on which the programs are 

based, we issue regulations under the 

authority granted to the Secretary of the 

Department of Health and Human 

Services under sections 1102, 1871, 

1902, and related provisions of the 

Social Security Act (the Act) and Public 

Health Service Act. We also issue 

various manuals, memoranda, and 

statements necessary to administer and 

oversee the programs efficiently. 

Section 1871(c) of the Act requires 

that we publish a list of all Medicare 

manual instructions, interpretive rules, 

statements of policy, and guidelines of 

general applicability not issued as 

regulations at least every 3 months in 

the Federal Register. 

II. Format for the Quarterly Issuance 

Notices 

This quarterly notice provides only 

the specific updates that have occurred 

in the 3-month period along with a 

hyperlink to the full listing that is 

available on the CMS website or the 

appropriate data registries that are used 

as our resources. This is the most 

current up-to-date information and will 

be available earlier than we publish our 

quarterly notice. We believe the website 

list provides more timely access for 

beneficiaries, providers, and suppliers. 

We also believe the website offers a 


khammond on DSKJM1Z7X2PROD with NOTICES